Global Pruritus Therapeutics
Market is expected to reach USD 16.38 Billion by 2025, according to a new study
by Grand View Research, Inc. Growing worldwide prevalence of atopic dermatitis,
allergic contact dermatitis and urticaria is expected to drive market growth
during the forecast period. Introduction of new products based on scientific
mechanistic understanding such as the identification of new T-cell subsets,
particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus)
is expected to open up new avenues for manufacturers to capitalize on over the
forecast period.
Corticosteroids were the
leading product segment in 2013 owing to high efficacy exhibited by this class
of drugs in treating pruritic conditions by reducing inflammation and itching.
Topical applications of corticosteroids have been found to be extremely
effective in the treatment and maintenance therapies pertaining to pruritus.
In depth research report on Pruritus Therapeutics Market
Further key findings from the study suggest:
·
Calcineurin inhibitor is
identified as the most lucrative segment of the market on account of high usage
rate of these drugs in combination therapy for the treatment of pruritus in
patients suffering from chronic pruritus and growing market penetration rates.
Moreover, the introduction of new products such as Pimecrolimus cream and
Tacrolimus ointment is expected to further drive this market.
·
Anti-histamines owing to its
growing use as a first line treatment and presence of drugs in pipeline with
expected commercialization is also expected to grow at a healthy rate during
the forecast period.
·
North America led the overall
market in terms of revenue in 2013 majorly on account of the presence of high
prevalence of diseases associated with pruritus, introduction of new products
targeting the unmet medical needs and growing patient awareness levels.
·
The Asia Pacific pruritus
therapeutics market is expected to grow at a CAGR of over 5.0% during the
forecast period. Presence of high unmet healthcare needs and increasing
prevalence of allergic contact dermatitis and urticaria in this region are some
factors attributing to its rapid growth rate.
·
Some key participants of the pruritus
therapeutics market include Sanofi, Pfizer, Tai Guk Pharmaceutical Company,
Actavis, Trevi Therapeutics, Cara Therapeutics, Ocera Therapeutics Inc. and
NeRRe Therapeutics.
·
Manufacturers adhere to
rigorous R&D in an attempt to develop cost effective products and avoid
barriers such as product recalls. In addition, this strategy is implemented
keeping the unmet needs in consideration. For Instance, Creabilis has a
molecule in the pipeline – CT327, which caters to the unmet needs associated
with pruritus in patients suffering from psoriasis.
For the purpose of this study,
Grand View Research has segmented the global pruritus therapeutics market on
the basis of product, disease type and region:
Global Pruritus Therapeutics Product Outlook (Revenue, USD
Million, 2012 - 2025)
·
Corticosteroids
·
Antihistamines
·
Local Anesthetics
·
Counterirritants
·
Immunosuppressant
·
Calcineurin Inhibitors
·
Others
Global Pruritus Therapeutics Disease Type Outlook
(Revenue, USD Million, 2012 - 2025)
·
Atopic Dermatitis
·
Allergic Contact Dermatitis
·
Urticaria
·
Others
Global Pruritus Therapeutics Regional Outlook (Revenue,
USD Million, 2012 - 2025)
·
North America
·
U.S.
·
Rest of North America
·
Europe
·
Germany
·
UK
·
France
·
Italy
·
Spain
·
Rest of Europe
·
Asia Pacific
·
Japan
·
Rest of Asia Pacific
·
RoW
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment